April 29, 2021
Burning Rock Schedules First Quarter of 2021 Earnings Release on May 25, 2021
GUANGZHOU, China, April 28, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a…
Pharmaceuticals, Biotechnology and Life Sciences
GUANGZHOU, China, April 28, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a…
ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2021 Q1 conference call Publication…
GW’s ground-breaking medicines development programme recognised for outstanding achievement in innovation with UK’s highest official award for British businessLONDON, April…
CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that it has received a Complete…
PLANO, Texas, April 28, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical…
LEXINGTON, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint…
AUSTIN, Texas and DURHAM, N.C., April 28, 2021 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology…
– Four presentations to focus on the clinically meaningful endpoint improvement, including the reduction of febrile neutropenia and hospitalization, shown…
AIRPORT CITY, Israel, April 28, 2021 (GLOBE NEWSWIRE) — Biosight Ltd., a pharmaceutical development company developing innovative therapeutics for hematological malignancies…
ATLANTA, April 28, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company that specializes in…